Literature DB >> 18923074

Myc's broad reach.

Martin Eilers1, Robert N Eisenman.   

Abstract

The role of the myc gene family in the biology of normal and cancer cells has been intensively studied since the early 1980s. myc genes, responding to diverse external and internal signals, express transcription factors (c-, N-, and L-Myc) that heterodimerize with Max, bind DNA, and modulate expression of a specific set of target genes. Over the last few years, expression profiling, genomic binding studies, and genetic analyses in mammals and Drosophila have led to an expanded view of Myc function. This review is focused on two major aspects of Myc: the nature of the genes and pathways that are targeted by Myc, and the role of Myc in stem cell and cancer biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18923074      PMCID: PMC2751281          DOI: 10.1101/gad.1712408

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  134 in total

1.  Skp2 regulates Myc protein stability and activity.

Authors:  So Young Kim; Andreas Herbst; Kathryn A Tworkowski; Simone E Salghetti; William P Tansey
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

2.  Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.

Authors:  Brian M Iritani; Jeffrey Delrow; Carla Grandori; Ivan Gomez; Meredith Klacking; Leni Sue Carlos; Robert N Eisenman
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

3.  Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line.

Authors:  Isabel Schlosser; Michael Hölzel; Reinhard Hoffmann; Helmut Burtscher; Franz Kohlhuber; Marino Schuhmacher; Rob Chapman; Ulrich H Weidle; Dirk Eick
Journal:  Oncogene       Date:  2005-01-13       Impact factor: 9.867

4.  The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60.

Authors:  Jagruti H Patel; Yanping Du; Penny G Ard; Charles Phillips; Beth Carella; Chi-Ju Chen; Carrie Rakowski; Chandrima Chatterjee; Paul M Lieberman; William S Lane; Gerd A Blobel; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

5.  Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment.

Authors:  Michaela Frye; Clare Gardner; Elizabeth R Li; Isabel Arnold; Fiona M Watt
Journal:  Development       Date:  2003-06       Impact factor: 6.868

6.  Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1.

Authors:  Jidong Zhu; John Blenis; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-01       Impact factor: 11.205

7.  Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

Authors:  Jacob Hanna; Styliani Markoulaki; Patrick Schorderet; Bryce W Carey; Caroline Beard; Marius Wernig; Menno P Creyghton; Eveline J Steine; John P Cassady; Ruth Foreman; Christopher J Lengner; Jessica A Dausman; Rudolf Jaenisch
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

8.  Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression.

Authors:  Daniel Y L Mao; John D Watson; Pearlly S Yan; Dalia Barsyte-Lovejoy; Fereshteh Khosravi; W Wei-Lynn Wong; Peggy J Farnham; Tim H-M Huang; Linda Z Penn
Journal:  Curr Biol       Date:  2003-05-13       Impact factor: 10.834

9.  The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry.

Authors:  Fionnuala Morrish; Nicola Neretti; John M Sedivy; David M Hockenbery
Journal:  Cell Cycle       Date:  2008-02-08       Impact factor: 4.534

10.  The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein.

Authors:  Xudong Zhao; Julian Ik-Tsen Heng; Daniele Guardavaccaro; Richeng Jiang; Michele Pagano; Francois Guillemot; Antonio Iavarone; Anna Lasorella
Journal:  Nat Cell Biol       Date:  2008-05-18       Impact factor: 28.824

View more
  478 in total

Review 1.  Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.

Authors:  Anouchka Skoudy; Inmaculada Hernández-Muñoz; Pilar Navarro
Journal:  J Gastrointest Cancer       Date:  2011-06

Review 2.  Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.

Authors:  Günter Schneider; Oliver H Krämer; Roland M Schmid; Dieter Saur
Journal:  J Gastrointest Cancer       Date:  2011-06

3.  Targeting MYC dependence in cancer by inhibiting BET bromodomains.

Authors:  Jennifer A Mertz; Andrew R Conery; Barbara M Bryant; Peter Sandy; Srividya Balasubramanian; Deanna A Mele; Louise Bergeron; Robert J Sims
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

4.  Solution structure of a 2:1 quindoline-c-MYC G-quadruplex: insights into G-quadruplex-interactive small molecule drug design.

Authors:  Jixun Dai; Megan Carver; Laurence H Hurley; Danzhou Yang
Journal:  J Am Chem Soc       Date:  2011-10-14       Impact factor: 15.419

Review 5.  PIM1: a promising target in patients with triple-negative breast cancer.

Authors:  Wen Zhao; RuiYue Qiu; Pan Li; Jin Yang
Journal:  Med Oncol       Date:  2017-07-18       Impact factor: 3.064

6.  Synthetic molecules for disruption of the MYC protein-protein interface.

Authors:  Nicholas T Jacob; Pedro O Miranda; Ryan J Shirey; Ritika Gautam; Bin Zhou; M Elena de Orbe Izquierdo; Mark S Hixon; Jonathan R Hart; Lynn Ueno; Peter K Vogt; Kim D Janda
Journal:  Bioorg Med Chem       Date:  2018-07-11       Impact factor: 3.641

Review 7.  The multifaceted functions of sirtuins in cancer.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

8.  MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.

Authors:  Brian J Altman; Annie L Hsieh; Arjun Sengupta; Saikumari Y Krishnanaiah; Zachary E Stine; Zandra E Walton; Arvin M Gouw; Anand Venkataraman; Bo Li; Pankuri Goraksha-Hicks; Sharon J Diskin; David I Bellovin; M Celeste Simon; Jeffrey C Rathmell; Mitchell A Lazar; John M Maris; Dean W Felsher; John B Hogenesch; Aalim M Weljie; Chi V Dang
Journal:  Cell Metab       Date:  2015-09-17       Impact factor: 27.287

9.  c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.

Authors:  Stefano La Rosa; Barbara Bernasconi; Alessandro Vanoli; Amedeo Sciarra; Kenji Notohara; Luca Albarello; Selenia Casnedi; Paola Billo; Lizhi Zhang; Maria Grazia Tibiletti; Fausto Sessa
Journal:  Virchows Arch       Date:  2018-05-02       Impact factor: 4.064

Review 10.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.